Literature DB >> 18809794

Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction.

Thierry Le Tourneau1, Sophie Susen, Claudine Caron, Alain Millaire, Sylvestre Maréchaux, Anne-Sophie Polge, André Vincentelli, Frederic Mouquet, Pierre-Vladimir Ennezat, Nicolas Lamblin, Pascal de Groote, Eric Van Belle, Ghislaine Deklunder, Jenny Goudemand, Christophe Bauters, Brigitte Jude.   

Abstract

BACKGROUND: Hypertrophic obstructive cardiomyopathy submits blood to conditions of high shear stress. High shear stress impairs von Willebrand factor (VWF) and promotes abnormal bleeding in aortic stenosis. We sought to evaluate VWF impairment and its relationships to baseline or exercise obstruction in hypertrophic cardiomyopathy (HCM). METHODS AND
RESULTS: Outflow obstruction was evaluated by rest and exercise echocardiography in 62 patients with HCM (age 44+/-16 years, 40 males). HCM was considered obstructive in 28 patients with rest or exercise peak gradient >or=30 mm Hg. Blood was sampled to assess VWF. History of bleeding was recorded. Baseline median (25th to 75th percentile) peak gradient was 11 (5-62) mm Hg. Shear-induced platelet adhesion was impaired in patients with obstructive HCM. The ratio of VWF-collagen-binding activity to antigen and the percentage of high-molecular-weight multimers of VWF were lower in patients with obstructive HCM than in those with nonobstructive HCM (0.49 [0.43 to 0.59] versus 0.82 [0.73 to 1.03] and 5.0% [3.9% to 7.2%] versus 11.7% [10.8% to 12.5%], respectively; both P<0.0001). Platelet adhesion time, VWF-collagen-binding activity-to-antigen ratio, and the percentage of high-molecular-weight multimers correlated closely and independently with peak gradient (r=0.81, r=-0.68, and r=-0.89, respectively; all P<0.0001). According to receiver operating characteristic curves, a peak gradient threshold of 15 mm Hg at rest and 35 mm Hg during exercise was sufficient to impair VWF. Conversely, VWF function tended to improve with a decrease in peak gradient. Obstructive HCM patients had a trend toward abnormal spontaneous bleeding.
CONCLUSIONS: In obstructive HCM, VWF impairment is frequent and is closely and independently related to the magnitude of outflow obstruction. A resting peak gradient of 15 mm Hg is sufficient to impair VWF. VWF abnormalities might favor abnormal bleeding in this setting.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809794     DOI: 10.1161/CIRCULATIONAHA.108.786681

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines.

Authors:  William L Nichols; Margaret E Rick; Thomas L Ortel; Robert R Montgomery; J Evan Sadler; Barbara P Yawn; Andra H James; Mae B Hultin; Marilyn J Manco-Johnson; Mark Weinstein
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

2.  Hypertrophic obstructive cardiomyopathy, acquired von Willebrand syndrome, and gastrointestinal bleeding.

Authors:  Rajiv K Pruthi
Journal:  Mayo Clin Proc       Date:  2011-03       Impact factor: 7.616

3.  The Role of Platelet Function Analyzer Testing in Cardiac Surgery Transfusion Management.

Authors:  Dejana Bogdanic; Nenad Karanovic; Jela Mratinovic-Mikulandra; Branka Paukovic-Sekulic; Dijana Brnic; Ivanka Marinovic; Diana Nonkovic; Nikolina Bogdanic
Journal:  Transfus Med Hemother       Date:  2017-02-01       Impact factor: 3.747

Review 4.  von Willebrand factor: at the crossroads of bleeding and thrombosis.

Authors:  Cécile V Denis; Peter J Lenting
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

5.  A case of hypertrophic obstructive cardiomyopathy and acquired von Willebrand syndrome: response to medical therapy.

Authors:  Masaki Wake; Nobuyuki Takahashi; Hiroyuki Yoshitomi; Kazuaki Tanabe
Journal:  J Echocardiogr       Date:  2014-05-10

6.  Hypertrophic obstructive cardiomyopathy, bleeding history, and acquired von Willebrand syndrome: response to septal myectomy.

Authors:  Joseph L Blackshear; Hartzell V Schaff; Steve R Ommen; Dong Chen; William L Nichols
Journal:  Mayo Clin Proc       Date:  2011-03       Impact factor: 7.616

7.  Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study).

Authors:  Joseph L Blackshear; Ewa M Wysokinska; Robert E Safford; Colleen S Thomas; Mark E Stark; Brian P Shapiro; Steven Ung; Gretchen S Johns; Dong Chen
Journal:  Am J Cardiol       Date:  2012-11-17       Impact factor: 2.778

8.  Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS).

Authors:  Claudia Heilmann; Ulrich Geisen; Friedhelm Beyersdorf; Lea Nakamura; Christoph Benk; Georg Trummer; Michael Berchtold-Herz; Christian Schlensak; Barbara Zieger
Journal:  Intensive Care Med       Date:  2011-10-01       Impact factor: 17.440

9.  Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).

Authors:  Joanna Rupa-Matysek; Krzysztof Lewandowski; Maria Lewandowska; Ewelina Wojtasińska; Marzena Liliana Wojtaszewska; Michał Walczak; Ksenia Bykowska; Mieczysław Komarnicki
Journal:  Int J Hematol       Date:  2014-11-29       Impact factor: 2.490

Review 10.  Gastrointestinal Bleeding in Native and Prosthetic Valve Disease.

Authors:  Joseph L Blackshear
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.